CDKN2A and neoplasm: We observed upregulation of CDKN2A and WNT7B in tumor tissues, potentially driven by increased proportions of basal epithelial cells, ciliated epithelial cells, and stem-like adenocarcinoma cells (Appendix Fig. S8).